Australia's largest stock trading and investment forum Australia's #1 stock forum

PBT

Click for more information

0.00%

0.0¢ prana biotechnology limited

Phase1 may demonstrate target engagement, page-24

First 24 Last

Share
Profile

Follow
skint

3,630 Posts.

116

29/05/18

16:48

Post #: 33356909
Share

Originally posted by skint ↑

The last PBT2 remarks from the 2017 annual report were "Following the Company’s review of its development programs, further development of PBT2 will remain on hold." from the chairman's letter. Further into the report regarding PBT2 development "Given the safety and efficacy data to date with PBT2, Prana is reviewing its options to either undertake additional non-clinical studies in the dog, development opportunities at dosing levels permitted by the FDA and/or alternative therapeutic applications of PBT2 that require shorter terms of administration."

Now this is interesting. In the IP section of the report: " Also in the last 12 months, a case has transitioned from a Provisional application to new PCT patent application, directed to a new use for PBT2 that is not a neurodegenerative disease."

I hope they remember what was said in the Dec 2016 update "the use of PBT2 at lower doses (as currently permitted by the FDA), or using PBT2 for acute indications requiring shorter term use, all with the aim of realising shareholder value from this part of its IP portfolio."

Expand

Reading that again, perhaps the chairmans letter trumps everything that was said about PBT2 in the 2017 report about development opportunities review.

PBT Price at posting: 4.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

There are more pages in this discussion • 13 more messages in this thread...

First 24 Last

Add PBT (ASX) to my watchlist